May 17, 2020

FutureNet leads the way in medical transcription services

Medical transcription
2 min
FutureNet has been named the KLAS Category Leader for 2015-16 for medical transcription services.
A corporation that provides cloud-based clinical documentation services and technology, FutureNet has been named the KLAS Category Leader for 2015-16 fo...

A corporation that provides cloud-based clinical documentation services and technology, FutureNet has been named the KLAS Category Leader for 2015-16 for medical transcription services.

Based on random client survey results, FutureNet is the only 100 percent domestic labor service option among the nationally ranked vendors and was recognized for exceptional implementation and training, living up to expectations, and overall communications. 

RELATED TOPIC: How GE's health cloud will transform the healthcare sector

Universally acknowledged as the gold standard in accurate, honest, and impartial healthcare vendor evaluations, KLAS Research awards annual Best in KLAS designation to the top ranked service and technology vendors according to their comprehensive user surveys.

"We've been amongst the industry leaders since we were first ranked by KLAS and have always had a higher percentage of positive user comments than our competitors," said Dale Kivi, vice president of business development.  "Although not considered in their overall scoring methodology, we consider that the strongest indicator of our true performance, when respondents go off the scripted questions and tell them what they really feel about us.  Especially in an industry that operates under the ‘no news is good news’ mentality, it's great to be recognized by KLAS for our efforts."

RELATED TOPIC: Why the cloud is the safest place to store medical records

The 2015-16 Best in KLAS rankings were determined by the average scores of sixteen separate survey questions grouped under four categories: Sales and Contracting, Implementation and Training, Service and Support, and General.  The General category addressed topics such as Real Problem Resolution, Overall Communications, Likely to Recommend, Overall Satisfaction, and Ranked as Client's Best Vendor. 

FutureNet was judged as above average on all these criteria and considered as their client's best vendor by a full 80 percent of respondents, by far outpacing their nearest competitor.

"Our KLAS rankings directly reflects our focus on exceeding client's expectations," said Tom Liu, founder and president of FutureNet. "Whether its transcription or coding, services or technology, for 20 years, our only goal has been to cost effectively deliver superior results that are easy to measure.  Our top ranking with KLAS validates our entire team's effort to proactively meet our clients' needs."

Let's connect!   

Click here to read the latest edition of Healthcare Global magazine!


Share article

Jun 18, 2021

Skin Analytics wins NHSX award for AI skin cancer tool 

2 min
Skin Analytics uses AI to detect skin cancer and will be deployed across the NHS to ease patient backlogs

An artificial intelligence-driven tool that identifies skin cancers has received an award from NHSX, the NHS England and Department of Health and Social Care's initiative to bring technology into the UK's national health system. 

NHSX has granted the Artificial Intelligence in Health and Care Award to DERM, an AI solution that can identify 11 types of skin lesion. 

Developed by Skin Analytics, DERM analyses images of skin lesions using algorithms. Within primary care, Skin Analytics will be used as an additional tool to help doctors with their decision making. 

In secondary care, it enables AI telehealth hubs to support dermatologists with triage, directing patients to the right next step. This will help speed up diagnosis, and patients with benign skin lesions can be identified earlier, redirecting them away from dermatology departments that are at full capacity due to the COVID-19 backlog. 

Cancer Research has called the impact of the pandemic on cancer services "devastating", with a 42% drop in the number of people starting cancer treatment after screening. 

DERM is already in use at University Hospitals Birmingham and Mid and South Essex Health & Care Partnership, where it has led to a significant reduction in unnecessary referrals to hospital.

Now NHSX have granted it the Phase 4 AI in Health and Care Award, making DERM available to clinicians across the country. Overall this award makes £140 million available over four years to accelerate the use of artificial intelligence technologies which meet the aims of the NHS Long Term Plan.

Dr Lucy Thomas, Consultant Dermatologist at Chelsea & Westminster Hospital, said: “Skin Analytics’ receipt of this award is great news for the NHS and dermatology departments. It will allow us to gather real-world data to demonstrate the benefits of AI on patient pathways and workforce challenges. 

"Like many services, dermatology has severe backlogs due to the COVID-19 pandemic. This award couldn't have come at a better time to aid recovery and give us more time with the patients most in need of our help.”

Share article